32
Participants
Start Date
August 1, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
February 28, 2026
SPG302
small synthetic molecule
Placebo
Placebo
COMPLETED
Multidisciplinary Alfred Psychiatry Research Centre (MAPrc), Melbourne
COMPLETED
Box Hill Hospital - Eastern Health, Box Hill
RECRUITING
CenExel CNS, Garden Grove
Lead Sponsor
Spinogenix
INDUSTRY